Siemens has completed the acquisition of Dotmatics, a provider of Life Sciences R&D software headquartered in Boston and portfolio company of global software investor Insight Partners, for an enterprise value of $5.1 billion.
With the transaction now completed, Dotmatics will form part of Siemens’ Digital Industries Software business, marking a significant expansion of Siemens’ industry-leading Product Lifecycle Management (PLM) portfolio into the rapidly growing and complementary Life Sciences market.
The acquisition of Dotmatics strengthens Siemens’ position as a global leader in AI- powered PLM software and enables Siemens to scale its technologies into Life Sciences to fully address growth opportunities in this market.
Dotmatics’ Scientific Intelligence Platform, Luma, and its scientific applications enable AI-powered multi-modal drug development, seamless collaboration, and contextualized data creating a connected digital thread across the research-to- production value chain.
“We combine Dotmatics’ scientific intelligence with our industrial AI technologies and digital twins,” said Roland Busch, president and CEO of Siemens. “This will allow us to help our customers accelerate breakthroughs, reduce development cycles, and bring life-saving pharmaceuticals faster and more affordably to the market.”
This transaction expands Siemens’ total addressable market for industrial software by $11 billion and aligns with ‘ONE Tech Company’, the company’s strategic growth program, aimed at accelerating innovation and creating value across industries.
